In this study, we have characterized the BRAF and NRAS mutation status of a series of melanoma cell lines developed from New Zealand patients with metastatic melanoma (Marshall et al., 1994; Charters et al., 2011; Kim et al., 2012). Here, BRAF is linked to metastatic melanoma.